Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:2261-2276, doi:10.1016/j.jacc.2009.09.012 (Published online 24 November 2009).
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Becker, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Becker, R. C.
Related Collections
Right arrowRelated Articles

Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures

Richard C. Becker, MD*,*, James Scheiman, MD{dagger}, Harold L. Dauerman, MD{ddagger}, Frederick Spencer, MD§, Sunil Rao, MD||, Marc Sabatine, MD, David A. Johnson, MD#, Frances Chan, MD**, Neena S. Abraham, MD{dagger}{dagger}, Eamonn M.M. Quigley, MD{ddagger}{ddagger} in collaboration with the American College of Cardiology and the American College of Gastroenterology

* Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina
{dagger} University of Michigan, Ann Arbor, Michigan
{ddagger} University of Vermont, Burlington, Vermont
§ McMaster University, Hamilton, Ontario, Canada
|| Durham VA Medical Center, Durham, North Carolina
Brigham and Women's Hospital, Boston, Massachusetts
# Eastern Virginia School of Medicine, Norfolk, Virginia
** Chinese University of Hong Kong, Hong Kong, China
{dagger}{dagger} Baylor College of Medicine, Houston, Texas
{ddagger}{ddagger} National University of Ireland at Cork, Cork, Ireland


Figure 1
View larger version (9K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Risk of Clinical Events After Clopidogrel Cessation

Risk-adjusted instantaneous incidence rates of death or acute myocardial infarction over time after stopping treatment with clopidogrel among medically treated and percutaneous coronary intervention (PCI)-treated patients with acute coronary syndrome. Reprinted with permission from Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008;299:532–9.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement